Posted in M&A / Deals Adcendo secures $75m in Series C funding for ADC development April 15, 2026 Pharmaceutical Technology Adcendo, a clinical-stage biotechnology company developing ADCs for cancer treatment, has raised $75m in a Series C funding round. M&A / DealsOncologyRead full story